Grants per year
Personal profile
Professional Affiliations
|
St. Joseph Orange |
Fingerprint
Dive into the research topics where Krishnansu Tewari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cancer Center Support Grant
Atiba, J. O., Burger, R. A., Cahalan, M. D., Fruehauf, J. P., Glabe, C., Henschen-edman, A. H., Krolewski, J. J., Lander, A., Lin, F., McLaren, C. E., Mevskens, F., Meyskens, F. L., Meyskens, F. L., Moyzis, R. K., Nalcioglu, O., Sandmeyer, S., Schell, M. J., Villarreal, L. P., Van Etten, R. R. A., Ganesan, A. A. K., Hamkalo, B. B. A., Blumberg, B., Hui, C. C. N., Hui, C. C. N., Nelson, E. E. L., Edwards, R. A., Meyskens, F. F. L., Fruman, D. A., Gershon, P. D., Gillen, D. L., Greenfield, S., Gulsen, G., Hsiang, D., Hughes, C. C. W., Milam, J. J. E., Lowengrub, J. J., Carmichael, J. J., Lander, A. D., Villarreal, L. L. P., Macgregor, G. R., Marsh, L. J., Kohler, M. F., Cahalan, M. D., Waterman, M. M. L., Funes, M. M., Poulos, T. L., Niece, R. R., Su, M. L., Lee, S. S., O'brien, S. S. M., Tanjasiri, S. S. P., Tewari, K., Kurosaki, T. T. & Wenzel, L.
08/15/94 → 01/31/25
Project: Research
-
-
Novel biologic markers of treatment resistance in locally advanced cervical carci
Tewari, K. & Fruehauf, J. P.
01/1/11 → 12/31/15
Project: Research
-
A review of racial disparities in ovarian cancer and clinical trials
Ali, M. & Tewari, K. S., Feb 1 2024, In: Current Opinion in Obstetrics and Gynecology. 36, 1, p. 23-27 5 p.Research output: Contribution to journal › Review article › peer-review
-
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators, Jan 6 2024, In: The Lancet. 403, 10421, p. 31-43 13 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Immunotherapy plus chemoradiotherapy in cervical cancer management
Tewari, K. S. & Monk, B. J., 2024, (Accepted/In press) In: The Lancet.Research output: Contribution to journal › Comment/debate
-
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)
OVAL/GOG-3018 Investigators, Jan 10 2024, In: Journal of Clinical Oncology. 42, 2, p. 170-179 10 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Pembrolizumab or Placebo Plus Chemotherapy with or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses from the KEYNOTE-826 Randomized Clinical Trial
Tewari, K. S., Colombo, N., Monk, B. J., Dubot, C., Cáceres, M. V., Hasegawa, K., Shapira-Frommer, R., Salman, P., Yañez, E., Gümüş, M., Olivera Hurtado De Mendoza, M., Samouëlian, V., Castonguay, V., Arkhipov, A., Tekin, C., Li, K., Toker, S., Keefe, S. M. & Lorusso, D., 2024, (Accepted/In press) In: JAMA Oncology.Research output: Contribution to journal › Article › peer-review
1 Scopus citations